Product Directory — Diagnostics, Devices & Equipment

OSOM® Ultra Plus Flu A&B Test

OSOM^® Ultra Plus Flu A&B Test Stronger Clinical Performance Takes Lateral Flow Testing To The Next Level Providing superior rapid results at the point-of-care. Fast, easy, cost effective so you can test and treat in one visit.

• High Performance
• Equivalent to or exceeding the performance of reader devices, without the need for an instrument
• Results in 10 minutes
• Exceptional Support/Training by licensed medical technologists and experienced healthcare professionals
• Made in the USA
• Award-winning supply chain capabilities
• Simple CLIA-waived procedure with pre-measured extraction buffer for swab samples

The OSOM^®Ultra Plus Flu A & B Test is an in vitro rapid qualitative test that detects influenza type A and type B nucleoprotein antigens directly from nasal swab and nasopharyngeal swab specimens obtained from patients with signs and symptoms of respiratory infection.

*Refer to the Package Insert for additional performance claims.

Silaris

Silaris^® Influenza A&B Test The CLIA Waived Silaris^® Influenza A&B Test is a molecular diagnostic test utilizing polymerase chain reaction (PCR) technology providing accurate results for early diagnosis and proper management of influenza. Features and Benefits

• Accurate Molecular PCR Results
• Influenza A: Sensitivity 97% & Specificity 94%
• Influenza B: Sensitivity 94% & Specificity 99%
• Affordable
• Definitive diagnosis (no confirmation required)
• Controls included with each kit
• SIMPLE
• Simple three step procedure and minimal hands on time of <1 minute
• No refrigeration required

Description	Catalog#	Configuration	Storage	Shelf Life
Silaris®Influenza A&B Test	1027	25 Test	Room Temperature	18 months
Silaris®Influenza A&B Control Kit	1024	5 - A+/B- Control Swabs;5- A-/B+ Control Swabs	Room Temperature	18 months
Silaris®Influenza A&B Starter Pack	1028	50 Tests;1 – Silaris Dock	Room Temperature
Silaris®Dock	1026	1 - Dock	Room Temperature	3000 Tests

View Brochures and Additional Information

BD Veritor System

Take testing to patients with the BD Veritor^TM Plus System

The BD Veritor^TM Plus System is the portable, easy-to-use testing system that delivers reliable results in just minutes. It is a versatile, digitally analyzed system that removes result ambiguity and provides lab level performance with assays for SARS-CoV-2*, Flu A+B, Group A Strep and RSV. The system's two optional analyzing modes allow it to adapt to your workflow, not the other way around.

The BD Veritor^TM Plus System has several reporting capabilities* that can allow you to have printed records, barcode scanning functionality and full connectivity with the BD Synapsys&trade Informatics Solution option. Most importantly, the system is supported by BD who provides eLearning training and ongoing support, making testing simple while allowing you to focus on providing the best possible patient experience.

*EUA authorized by FDA

cobas® Influenza A/B & RSV assay

cobas® Influenza A/B & RSV assay The cobas Influenza A/B & RSV assay is the first CLIA-waived, real-time PCR test that differentiates Influenza A, Influenza B and RSV in 20 minutes. It's available for use in hospitals, physician offices and urgent care settings. Benefits:

• Lab-quality performance in the detection and differentiation of Influenza A, Influenza B and RSV strains
• Fast results, 20-min. turnaround time
• Simplicity—minimal hands-on time, walkaway test with easy results interpretation
• Supports timely, confident treatment decisions

cobas® Influenza A/B assay

cobas® Influenza A/B assay The cobas® Influenza A/B assay is the first CLIA-waived, real-time PCR test to detect Influenza A and B in ~20 minutes. Available for use in non-traditional testing sites, including ERs, physician offices, pharmacy clinics and other urgent care settings. Benefits:

• Lab-quality performance in the detection and differentiation of Influenza A and Influenza B
• Fast results—20-min. turnaround time
• Simplicity—minimal hands-on time, walk-away test with easy results interpretation
• Supports timely, confident treatment decisions

BioFire FilmArray® Torch

The BioFire^® FilmArray^® Torch is a fully integrated, random, and continuous access system designed to meet your laboratory's syndromic infectious disease testing needs. The BioFire Torch offers a radically reduced benchtop footprint, saving precious space in the lab, and its scalability meets high throughput demands. BioFire^® FilmArray^® Link Software automatically uploads patient results. Fully compatible with all CLIA Moderate BioFire^® FilmArray^® Panels, the BioFire Torch helps you maximize efficiency and productivity.

FilmArray^® Respiratory Panel EZ (RP EZ)

Nail it with one swab with The BioFire^® FilmArray^® Respiratory Panel EZ (RP EZ) 1 test. 14 respiratory pathogens. The BioFire RP EZ uses a molecular syndromic approach to accurately detect and identify a wide range of pathogens—not just Flu A and Flu B. As a healthcare provider, this means your patients can receive the right treatment the first time, potentially leading to higher patient satisfaction and lower costs. And as the name implies, it’s easy and can be performed right in your office or clinic.¹ Because a large number of pathogens cause respiratory infections, tests that only identify Flu A and B run the risk of missing the real culprit. Many rapid influenza diagnostic tests sacrifice accuracy for speed, with sensitivities ranging from 50-70%.² The BioFire RP EZ provides an accurate, comprehensive alternative to targeted influenza testing, and will detect a greater number of pathogens no matter the season or the time of year.^{3 1}CLIA Certificate of Waiver required to perform testing. ²http://www.cdc.gov/flu/professionals/diagnosis/rapidlab.htm ³Schreckenberger PC, McAdam AJ. J Clin Microbiol. 2015;53:3110-3115.